
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


ZR2 Bioenergy Ltd (GUJCMDS) is currently trading at 144.95 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Gujchem Distillers India Limited (GDIL) is engaged in the manufacture and sale of industrial alcohol, acetaldehyde, acetic acid, and chemicals in India. Established initially as a proprietary concern in 1911, GDIL has evolved over a century into a public limited company with a diverse chemical product portfolio. In a strategic move towards diversification, GDIL has incorporated a wholly-owned subsidiary, Sera Code Private Limited, to venture into the Information Technology sector. The introduction of Sera Code Private Limited marks GDIL's entry into the technology arena, signifying a potential shift in its business strategy.
Over the past 52 weeks, ZR2 Bioenergy Ltd has traded between a low of ₹142.15 and a high of ₹456.50. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
ZR2 Bioenergy Ltd has a market capitalization of approximately 56.35. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
ZR2 Bioenergy Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 132.69 and operates in the Trading sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
You can buy shares of ZR2 Bioenergy Ltd (GUJCMDS) through any SEBI-registered stockbroker in India. A demat and trading account are required to place buy or sell orders on stock exchanges such as NSE or BSE. Shares are credited to the demat account as per the exchange settlement cycle.
Based on its market capitalization of 56.35 Cr, ZR2 Bioenergy Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
ZR2 Bioenergy Ltd operates in the Trading sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of ZR2 Bioenergy Ltd is 132.69. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
ZR2 Bioenergy Ltd currently does not pay dividends. Companies that do not pay dividends often reinvest profits to support business growth or strengthen operations.
Key risks associated with ZR2 Bioenergy Ltd include sector-specific challenges in the Trading industry, regulatory changes, competitive pressures, company-level financial performance, overall market volatility, and broader macroeconomic factors that can impact stock prices.
Bearish
4
Neutral
2
Bullish
8
Bearish
36
Neutral
2
Bullish
8
Bearish
32
Neutral
0
Bullish
0
Trading
Trading - Medium / Small
56 Cr
Low Risk
132.7
32.4
—
0.4
456.50
142.15
Sales CAGR
1Y
-5.10%
3Y
8.95%
5Y
—
10Y
—
Profit CAGR
1Y
-79.49%
3Y
-40.60%
5Y
—
10Y
-29.63%
ROE
TTM
0.30%
3Y
0.32%
5Y
0.59%
10Y
0.83%
ROCE
TTM
0.39%
3Y
0.47%
5Y
0.68%
10Y
1.58%
Market Cap
₹ 56 Cr
P/E
132.69
Performance
STEADY PERFORMER
Valuation
OVERVALUED
Growth
SLUGGISH
Profitability
LOW MARGIN
Technicals
Bearish
Risk
MODERATE RISK
Turned 1 L into 10.82 L in last 5 Years
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone